Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase 2 NeoCOAST Platform Trial Published Date November 15, 2023 Cascone T, Kar G, Spicer JD, et al. Cancer Discov. 2023 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen